343 related articles for article (PubMed ID: 17638340)
1. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
[TBL] [Abstract][Full Text] [Related]
2. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
3. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
[TBL] [Abstract][Full Text] [Related]
4. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
[TBL] [Abstract][Full Text] [Related]
6. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
7. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.
Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
9. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
[TBL] [Abstract][Full Text] [Related]
10. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
12. Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum.
Bigham AK; Munro TA; Rizzacasa MA; Robins-Browne RM
J Nat Prod; 2003 Sep; 66(9):1242-4. PubMed ID: 14510607
[TBL] [Abstract][Full Text] [Related]
13. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
14. Clerodane diterpenoids from Salvia splendens.
Fontana G; Savona G; Rodríguez B
J Nat Prod; 2006 Dec; 69(12):1734-8. PubMed ID: 17190451
[TBL] [Abstract][Full Text] [Related]
15. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
[TBL] [Abstract][Full Text] [Related]
16. Complete 1H and 13C NMR assignments of clerodane diterpenoids of Salvia splendens.
Fontana G; Savona G; Rodríguez B
Magn Reson Chem; 2006 Oct; 44(10):962-5. PubMed ID: 16835898
[TBL] [Abstract][Full Text] [Related]
17. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
[TBL] [Abstract][Full Text] [Related]
18. New clerodane diterpenoids from Casearia sylvestris.
Wang W; Ali Z; Li XC; Smillie TA; Guo DA; Khan IA
Fitoterapia; 2009 Oct; 80(7):404-7. PubMed ID: 19465090
[TBL] [Abstract][Full Text] [Related]
19. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
Shirota O; Nagamatsu K; Sekita S
J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
[TBL] [Abstract][Full Text] [Related]
20. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
